Martine Cleusix

N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis

Philippe Conus, Larry J. Seidman, Margot Fournier et al. · Schizophrenia Bulletin · 2017 · 162 citations · Full text

Medicine, Pharmacology, Psychiatry +15

MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients

Daniella Dwir, Basilio Giangreco, Lijing Xin et al. · Molecular Psychiatry · 2019 · 134 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia

Antonio F. Pardiñas, Sophie E. Smart, Isabella Willcocks et al. · JAMA Psychiatry · 2022 · 106 citations · Full text

Life Sciences, Genetics, Psychiatry +17

Mitochondrial, exosomal miR137-COX6A2 and gamma synchrony as biomarkers of parvalbumin interneurons, psychopathology, and neurocognition in schizophrenia

Inès Khadimallah, Raoul Jenni, Jan-Harry Cabungcal et al. · Molecular Psychiatry · 2021 · 86 citations · Full text

Life Sciences, Neuroscience, Psychiatry +16

Brain connectivity alterations in early psychosis: from clinical to neuroimaging staging

Alessandra Griffa, Philipp Baumann, Paul Klauser et al. · Translational Psychiatry · 2019 · 62 citations · Full text

Medicine, Neuroscience, Psychiatry +16